The present invention relates to use of a tall oil fatty acid and/or a tall oil fatty acid which is modified by saponification in binding toxins.

The present disclosure relates to an herbal composition and a method of administering the composition including administering the composition in pill or capsule form on a routine basis for the purpose of increasing energy, alertness, clarity, memory, and sexual enhancement in individuals, and particularly in males.

The present disclosure relates to an herbal composition and a method of administering the composition including administering the composition in pill or capsule form on a routine basis for the purpose of increasing energy, alertness, clarity, memory, and sexual enhancement in individuals, and particularly in males.

The present invention relates to a cosmetic or pharmaceutical formulation comprising a hyaluronate crosspolymer and one or more of (a) azelaic acid or an ester thereof; (b) one or more of black cumin seed oil, chaulmoogra oil, magnolia bark extract and manuka oil; and (c) resveratrol or a derivative thereof. Uses of the formulation for skin treatments, promoting collagen production and regulating cellular turnover are also described.

The present invention relates to use of a tall oil fatty acid in the modulation of microbial population of the animal digestive tract. The invention further relates to use of a feed supplement and a feed composition comprising tall oil fatty acid.

The present invention relates to use of a tall oil fatty acid in the modulation of microbial population of the animal digestive tract. The invention further relates to use of a feed supplement and a feed composition comprising tall oil fatty acid.

The present invention relates to a tall oil fatty acid which is modified by saponification for use in the prevention of growth of harmful bacteria in the animal digestive tract and/or in the prevention of intestinal disorders. The invention further relates to a feed supplement and a feed composition comprising tall oil fatty acid which is modified by saponification.

The present invention relates to a tall oil fatty acid which is modified by saponification for use in the prevention of growth of harmful bacteria in the animal digestive tract and/or in the prevention of intestinal disorders. The invention further relates to a feed supplement and a feed composition comprising tall oil fatty acid which is modified by saponification.

The present invention relates to a composition for the prevention, improvement/amelioration or treatment of allergic disease containing an extract of Taxus cuspidata as an active ingredient, and more specifically, to a composition for the prevention, improvement/amelioration or treatment of allergic respiratory disease comprising an ethanol extract of Taxus cuspidata or a fraction thereof as an active ingredient. In the present invention, the effectiveness of Taxus cuspidata extract in treating allergic respiratory disease was confirmed in an animal model of allergic asthma, and the anti-allergic efficacy of compounds isolated from Taxus cuspidata ethanol extract was confirmed. Therefore, Taxus cuspidata extract of the present invention can be useful as a composition for the prevention, amelioration or treatment of allergic respiratory diseases, particularly allergic asthma or allergic bronchitis.

The present invention relates to a composition for the prevention, improvement/amelioration or treatment of allergic disease containing an extract of Taxus cuspidata as an active ingredient, and more specifically, to a composition for the prevention, improvement/amelioration or treatment of allergic respiratory disease comprising an ethanol extract of Taxus cuspidata or a fraction thereof as an active ingredient. In the present invention, the effectiveness of Taxus cuspidata extract in treating allergic respiratory disease was confirmed in an animal model of allergic asthma, and the anti-allergic efficacy of compounds isolated from Taxus cuspidata ethanol extract was confirmed. Therefore, Taxus cuspidata extract of the present invention can be useful as a composition for the prevention, amelioration or treatment of allergic respiratory diseases, particularly allergic asthma or allergic bronchitis.